Stem definition | Drug id | CAS RN |
---|---|---|
serotonin reuptake inhibitors | 2436 | 79617-96-2 |
Dose | Unit | Route |
---|---|---|
50 | mg | O |
Property | Value | Reference |
---|---|---|
MRTD (Maximum Recommended Therapeutic Daily Dose) | 9.33 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 44 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
S (Water solubility) | 3.80 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 1 | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 0.20 % | Benet LZ, Broccatelli F, Oprea TI |
fu (Fraction unbound in plasma) | 0.00 % | Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, Ohashi R, Komura H, Mizuguchi K |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Intentional self-injury | 1376.95 | 9.64 | 969 | 234126 | 24718 | 63229209 |
Intentional overdose | 1252.14 | 9.64 | 1457 | 233638 | 72695 | 63181232 |
Serotonin syndrome | 946.96 | 9.64 | 812 | 234283 | 27870 | 63226057 |
Suicide attempt | 918.11 | 9.64 | 1130 | 233965 | 59788 | 63194139 |
Suicidal ideation | 853.49 | 9.64 | 1103 | 233992 | 61318 | 63192609 |
Drug abuse | 768.26 | 9.64 | 1133 | 233962 | 71385 | 63182542 |
Pemphigus | 662.03 | 9.64 | 3 | 235092 | 183723 | 63070204 |
Hand deformity | 528.56 | 9.64 | 13 | 235082 | 159444 | 63094483 |
Systemic lupus erythematosus | 506.35 | 9.64 | 83 | 235012 | 208835 | 63045092 |
Drug interaction | 485.83 | 9.64 | 1904 | 233191 | 227227 | 63026700 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Depression | 970.48 | 10.47 | 1390 | 114466 | 95708 | 34745367 |
Serotonin syndrome | 738.52 | 10.47 | 576 | 115280 | 19357 | 34821718 |
Drug interaction | 679.15 | 10.47 | 1958 | 113898 | 223988 | 34617087 |
Suicidal ideation | 648.79 | 10.47 | 733 | 115123 | 39655 | 34801420 |
Intentional self-injury | 448.30 | 10.47 | 369 | 115487 | 13402 | 34827673 |
Suicide attempt | 345.22 | 10.47 | 529 | 115327 | 38587 | 34802488 |
Anxiety | 336.21 | 10.47 | 901 | 114955 | 98527 | 34742548 |
Intentional overdose | 325.66 | 10.47 | 547 | 115309 | 43127 | 34797948 |
Completed suicide | 317.31 | 10.47 | 875 | 114981 | 97293 | 34743782 |
Drug abuse | 242.52 | 10.47 | 801 | 115055 | 98295 | 34742780 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Serotonin syndrome | 1509.98 | 9.63 | 1271 | 285993 | 43756 | 79413368 |
Intentional self-injury | 1481.00 | 9.63 | 1098 | 286166 | 31321 | 79425803 |
Suicidal ideation | 1332.51 | 9.63 | 1506 | 285758 | 74834 | 79382290 |
Intentional overdose | 1222.61 | 9.63 | 1699 | 285565 | 104261 | 79352863 |
Suicide attempt | 1136.91 | 9.63 | 1447 | 285817 | 81485 | 79375639 |
Drug interaction | 934.26 | 9.63 | 3448 | 283816 | 411735 | 79045389 |
Drug abuse | 899.14 | 9.63 | 1879 | 285385 | 160812 | 79296312 |
Depression | 762.28 | 9.63 | 2101 | 285163 | 214689 | 79242435 |
Anxiety | 670.90 | 9.63 | 2194 | 285070 | 246318 | 79210806 |
Completed suicide | 669.99 | 9.63 | 2177 | 285087 | 243590 | 79213534 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Agitation neonatal | 35.47 | 18.76 | 60 | 2171 | 588 | 86973 |
Premature baby | 28.68 | 18.76 | 34 | 2197 | 3894 | 83667 |
Human herpesvirus 6 infection | 21.16 | 18.76 | 15 | 2216 | 45 | 87516 |
Fever neonatal | 18.97 | 18.76 | 9 | 2222 | 8 | 87553 |
Source | Code | Description |
---|---|---|
ATC | N06AB06 | NERVOUS SYSTEM PSYCHOANALEPTICS ANTIDEPRESSANTS Selective serotonin reuptake inhibitors |
CHEBI has role | CHEBI:35469 | antidepressants |
CHEBI has role | CHEBI:50949 | SSRI |
FDA EPC | N0000175696 | Serotonin Reuptake Inhibitor |
FDA MoA | N0000000109 | Serotonin Uptake Inhibitors |
FDA MoA | N0000182137 | Cytochrome P450 2D6 Inhibitors |
MeSH PA | D000928 | Antidepressive Agents |
MeSH PA | D002491 | Central Nervous System Agents |
MeSH PA | D049990 | Membrane Transport Modulators |
MeSH PA | D018377 | Neurotransmitter Agents |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Premenstrual dysphoric disorder | indication | 596004 | |
Social phobia | indication | 25501002 | DOID:11257 |
Depressive disorder | indication | 35489007 | |
Posttraumatic stress disorder | indication | 47505003 | DOID:2055 |
Obsessive-compulsive disorder | indication | 191736004 | DOID:10933 |
Panic disorder | indication | 371631005 | DOID:594 |
Bipolar affective disorder, current episode depression | off-label use | 191627008 | DOID:3312 |
Seasonal affective disorder | off-label use | 247803002 | |
Cholestatic pruritus | off-label use | 707150004 | |
Suicidal thoughts | contraindication | 6471006 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 9.61 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Sodium-dependent serotonin transporter | Transporter | INHIBITOR | Kd | 9.54 | CHEMBL | CHEMBL | |||
Sigma non-opioid intracellular receptor 1 | Membrane receptor | Ki | 7.24 | CHEMBL | |||||
Potassium voltage-gated channel subfamily H member 2 | Ion channel | Ki | 5.17 | DRUG MATRIX | |||||
Sodium-dependent noradrenaline transporter | Transporter | Kd | 6.38 | WOMBAT-PK | |||||
5-hydroxytryptamine receptor 2A | GPCR | Ki | 6.11 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2B | GPCR | Ki | 5.67 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2C | GPCR | Ki | 6.25 | DRUG MATRIX | |||||
Alpha-1A adrenergic receptor | GPCR | Ki | 6.86 | WOMBAT-PK | |||||
Alpha-2B adrenergic receptor | GPCR | Ki | 7.08 | DRUG MATRIX | |||||
Muscarinic acetylcholine receptor M1 | GPCR | Ki | 6.13 | PDSP |
ID | Source |
---|---|
SRE | PDB_CHEM_ID |
003629 | NDDF |
004615 | NDDF |
155137 | RXNORM |
169461 | MMSL |
321958004 | SNOMEDCT_US |
372594008 | SNOMEDCT_US |
39959 | MMSL |
4020394 | VANDF |
4020551 | VUID |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0143-9654 | TABLET, FILM COATED | 100 mg | ORAL | ANDA | 31 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0143-9655 | TABLET, FILM COATED | 50 mg | ORAL | ANDA | 31 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0143-9656 | TABLET, FILM COATED | 25 mg | ORAL | ANDA | 31 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-7989 | TABLET, FILM COATED | 25 mg | ORAL | ANDA | 24 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-7989 | TABLET, FILM COATED | 25 mg | ORAL | ANDA | 24 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-7989 | TABLET, FILM COATED | 25 mg | ORAL | ANDA | 24 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-7990 | TABLET, FILM COATED | 50 mg | ORAL | ANDA | 24 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-7990 | TABLET, FILM COATED | 50 mg | ORAL | ANDA | 24 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-7990 | TABLET, FILM COATED | 50 mg | ORAL | ANDA | 24 sections |
Sertraline | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0615-7991 | TABLET, FILM COATED | 100 mg | ORAL | ANDA | 24 sections |